"
 
Perhimpunan Dokter Paru Indonesia - Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma
 
Link
Free Web Counters
Members
News
Mitra Kerja
Video
Tutorial Aplikasi ISR
Uploaded on May 11, 2015
World Asthma Day 2018
Uploaded on Apr 30, 2018
"
 

 

Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma

penyakit paru
image: rodpub.com


Naoto Watanabe1 and Sohei Makino1
1Tokyo Allergy and Respiratory, Disease Research Institute, Tokyo, Japan


Aim: We aimed to determine whether or not switching inhaled medication from twice a day to once a day would improve adherence and symptoms in patients with bronchial asthma.

Participants: Forty one patients (average age 48.7 years; 22 males, 19 females) with bronchial asthma who were prescribed with twice-daily combination drugs of inhaled corticosteroid (ICS)/long-acting beta-2 agonist (LABA)

Methods: The twice-daily regimen was changed to a regimen comprising once-daily inhalation of fluticasone furoate (FF)/vilanterol (VI), and the effects were evaluated using the Adherence Starts with Knowledge-20 (ASK-20) and a questionnaire survey of FF/VI.

Results: Among the 41 patients, 54% and 46% of them felt that the switch improved or did not change their symptoms, respectively.

One patient described palpitations as a side effect, and 30 (73%) patients responded that FF/VI was easy to inhale but 3 (7%) patients felt it was difficult to inhale.

Twenty one (51%), 2 (5%) and 8 (44%) patients inhaled the medication during the morning, midday and night, respectively.

The rate of patients who sometimes forgot to use their medication fell to 17% according to scores of ≥ 4 points in response to question 1 of the ASK-20.

Twenty four (80%) and 5 (17%) of 30 patients who scored ≥ 4 points in question 13 inhaled the same amount and more medication as before, respectively. The symptoms of 16 (53%) patients concurrently improved with better adherence.

Conclusions: Switching from ICS/LABA to FF/VI improved symptoms and adherence in about 50% of the patients.

Medication taken once a day can improve adherence in patients with bronchial asthma who feel that inhaling medication twice a day is inconvenient.



Source : http://erj.ersjournals.com/content/48/suppl_60/PA3364
Image : https://dev.rodpub.com/images/154/706_main.jpg



PDPI Surakarta. 10/11/17.




Halaman Siap Cetak  Halaman Siap Cetak

Kirimkan Pada Rekan  Kirimkan Pada Rekan